gefitinib has been researched along with epothilone b in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (epothilone b) | Trials (epothilone b) | Recent Studies (post-2010) (epothilone b) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 305 | 27 | 129 |
| Protein | Taxonomy | gefitinib (IC50) | epothilone b (IC50) |
|---|---|---|---|
| Tubulin beta-4A chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 0.0035 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayakawa, Y | 1 |
1 other study(ies) available for gefitinib and epothilone b
| Article | Year |
|---|---|
[Structure-activity relationship analysis].
Topics: Antineoplastic Agents; Benzamides; Camptothecin; Docetaxel; Drug Screening Assays, Antitumor; Epothilones; Gefitinib; Imatinib Mesylate; Irinotecan; Macrolides; Oligopeptides; Paclitaxel; Piperazines; Pyrimidines; Quinazolines; Structure-Activity Relationship; Taxoids; Topotecan; Vinblastine | 2004 |